20-11-2023 | Cholecystitis | Original Article
Usefulness of intraoperative bile culture in patients with acute calculous cholecystitis with previous biliary events: does the postoperative management change?
Authors:
Melissa Arias-Avilés, Jaume Tur-Martínez, Judith Camps-Lasa, Èric Herrero-Fonollosa, María Isabel García-Domingo, Esteban Cugat-Andorrà
Published in:
European Journal of Clinical Microbiology & Infectious Diseases
Login to get access
Abstract
Purpose
The aim of our study was to determine the usefulness of intraoperative gallbladder cultures in the postoperative course in surgically treated patients with acute calculous cholecystitis and previous biliary events (ACC-PBE).
Methods
Retrospective unicenter study on surgically treated ACC-patients between January 2014 and December 2018. Clinical benefit was defined as a > 20% change in postoperative antibiotic treatment. Secondary endpoints: postoperative morbidity and length-of-stay (LOS) in ACC-PBE patients with positive intraoperative biliary culture (IBC). Statistical significance was defined as p < 0.05.
Results
Out of the initial 711 patients, 203 met the study’s inclusion criteria, with 139 of them having IBC results (72 positive, 67 negative). Our analysis revealed no significant difference in the incidence of positive-IBC between patients with ACC-PBE. Among this group, only 6% changed postoperative antibiotic treatment based on IBC results. There were no statistically significant differences in postoperative complications (p: 0.21) or LOS (p: 0.23) in the ACC-PBE group. In multivariate analysis, age > 70 years old (p: 0.00; HR 3.1, 95% IC [1.6–6.4]), prior ERCP (p: 0.02; HR 5.9, 95% IC [1.25–27.5]) and prior antibiotic treatment (p: 0.01; HR 3.6, 95% IC [1.32–9.86]) were identified as independent factors that influenced PBC.
Conclusions
IBC in operated ACC-PBE do not alter postoperative management. While positive-IBC was associated with age, prior ERCP, and prior antibiotic treatment, these findings did not have a significant impact on postoperative morbidity or LOS.